AB-FUBINACA

Research chemical

Arguably the most common synthetic cannabinoid, AB-FUBINACA was originally developed by Pfizer as an analgesic, but has since abandoned for medical use. It has since found a following in the RC community, however it's extremely high potency and inclusion in synthetic blends makes it dangerous, and it has killed in overdose. Exercise caution.

ab-fub

Extended library — TripSit data only (PolyForm Noncommercial 1.0.0).

Before you dose

⚠This substance's dose is not reliably weight-scaled - the ranges shown are population figures. Sensitivity varies far more between people than body mass explains.

Dose

Published population range

Light0.25–0.5 mg

Common0.5–1.5 mg

Strong1.5–3 mg

Heavy / risk zone≥ 3 mg

No weight-based model. Unknown potency — start far below any published figure.

Check an amount you already have

Expected effects

Euphoric
Stimulating high
Increases creativity and appetite
Also short term memory deficits
Similar to cannabis

Harm reduction

This entry comes from the extended library: it is a less-studied substance with fewer independent sources.
Unknown potency is the main risk with novel substances — start with a fraction of any published figure and never re-dose before the full onset has passed.
Test with reagents and, where possible, a lab service. Fentanyl and nitazene contamination is not detectable by eye or by reagent alone.
Avoid using alone, and do not combine with other drugs while you are learning how a new substance affects you.

Sources

• TripSit wiki (PolyForm Noncommercial)
https://wiki.tripsit.me

Dosina is educational harm-reduction information, not medical advice. Doses are population ranges from published sources and cannot account for your tolerance, health conditions or what is actually in your substance. Possession and use may be illegal where you live.